» Articles » PMID: 8670319

Protein Metabolism in Rheumatoid Arthritis and Aging. Effects of Muscle Strength Training and Tumor Necrosis Factor Alpha

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 1996 Jul 1
PMID 8670319
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the effects of rheumatoid arthritis (RA) on whole-body protein metabolism.

Methods: We examined protein metabolism and its hormonal and cytokine mediators before and 12 weeks after progressive resistance muscle strength training in 8 healthy young (mean +/- SD age 25 +/- 2 years) and 8 healthy elderly (70 +/- 5 years) men and women, and in 8 adults with RA (42 +/- 13 years). An additional 6 healthy elderly subjects (69 +/- 3 years) served as a swimming-only control group.

Results: Subjects with RA had higher rates of protein breakdown than did young or elderly healthy subjects (79.9 +/- 17.2 versus 60.3 +/- 5.8 and 63.7 +/- 12.4 mumoles/gm total body potassium/hour, respectively, P < 0.05), while there was no effect of age per se. Patients treated with methotrexate had normal rates of protein breakdown (P < 0.01 versus RA without methotrexate; P not significant versus healthy young subjects). Increased protein catabolism in RA was no longer evident after strength training. In multiple regression analysis, levels of tumor necrosis factor alpha (TNF alpha) (r = 0.47, P = 0.01) and growth hormone (r = -0.51, P = 0.006) were associated with protein breakdown, and plasma glucagon levels were inversely correlated with protein synthesis (r = -0.45, P = 0.02). Growth hormone (r = -0.56, P = 0.002) and glucagon (r = 0.45, P = 0.04, levels were associated with protein oxidation.

Conclusion: Adults with RA have increased whole-body protein breakdown, which correlates with growth hormone, glucagon, and TNF alpha production.

Citing Articles

Natural biomimetic nano-system for drug delivery in the treatment of rheumatoid arthritis: a literature review of the last 5 years.

Li J, Li W, Zhuang L Front Med (Lausanne). 2024; 11:1385123.

PMID: 38784236 PMC: 11114446. DOI: 10.3389/fmed.2024.1385123.


Interaction effect of systemic inflammation and modifiable rheumatoid cachexia risk factors on resting energy expenditure in patients with rheumatoid arthritis.

Hanaoka B, Zhao J, Heitman K, Khan F, Jarjour W, Volek J JCSM Clin Rep. 2024; 7(1):12-23.

PMID: 38288252 PMC: 10824535. DOI: 10.1002/crt2.45.


Targeted co-delivery biomimetic nanoparticles reverse macrophage polarization for enhanced rheumatoid arthritis therapy.

Zheng X, Yu X, Wang C, Liu Y, Jia M, Lei F Drug Deliv. 2022; 29(1):1025-1037.

PMID: 35363114 PMC: 8979516. DOI: 10.1080/10717544.2022.2057616.


Molecular photoacoustic imaging for early diagnosis and treatment monitoring of rheumatoid arthritis in a mouse model.

Lin Y, Xiao S, Yao W, Lv Z, Tang Y, Zhang Y Am J Transl Res. 2021; 13(8):8873-8884.

PMID: 34540001 PMC: 8430181.


Impact of TNF-α Inhibitors on Body Weight and BMI: A Systematic Review and Meta-Analysis.

Patsalos O, Dalton B, Leppanen J, Ibrahim M, Himmerich H Front Pharmacol. 2020; 11:481.

PMID: 32351392 PMC: 7174757. DOI: 10.3389/fphar.2020.00481.